Uni-Bio Science Group Ltd. (HK:0690) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Uni-Bio Science Group Ltd. has achieved significant milestones with the approval of its recombinant collagen dressing as a Class II medical device and the launch of its proprietary medical aesthetics product, 肌顏態®. These developments are set to bolster the company’s diverse portfolio in skincare solutions, positioning it strongly in the growing medical aesthetics market. The company aims to leverage its innovative capabilities to become a leader in dermatology across China.
For further insights into HK:0690 stock, check out TipRanks’ Stock Analysis page.